BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33809217)

  • 81. Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study.
    Gallay L; Tran VT; Perrodeau E; Vignier N; Mahevas M; Bisio F; Forestier E; Lescure FX;
    Clin Microbiol Infect; 2021 Aug; 27(8):1145-1150. PubMed ID: 33819571
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID-19 infection.
    Ünsal YA; Gül ÖÖ; Cander S; Ersoy C; Aydemir E; Ateş C; Uzun Z; Armağan E; Ünsal O; Ertürk E
    J Endocrinol Invest; 2021 Dec; 44(12):2601-2607. PubMed ID: 33818731
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 2020.
    Katelaris AL; Wells J; Clark P; Norton S; Rockett R; Arnott A; Sintchenko V; Corbett S; Bag SK
    Emerg Infect Dis; 2021 Jun; 27(6):1677-1680. PubMed ID: 33818372
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2.
    Petrak RM; Van Hise NW; Skorodin NC; Fliegelman RM; Chundi V; Didwania V; Han A; Harting BP; Hines DW
    Crit Care Explor; 2021 Apr; 3(4):e0395. PubMed ID: 33817660
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression.
    Cavalier E; Guiot J; Lechner K; Dutsch A; Eccleston M; Herzog M; Bygott T; Schomburg A; Kelly T; Holdenrieder S
    Front Mol Biosci; 2021; 8():600881. PubMed ID: 33816549
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study.
    Mahajan L; Singh AP; Gifty
    Indian J Anaesth; 2021 Mar; 65(Suppl 1):S41-S46. PubMed ID: 33814589
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical features and risk factors associated with severe COVID-19 patients in China.
    Jiang N; Liu YN; Bao J; Li R; Ni WT; Tan XY; Xu Y; Peng LP; Wang XR; Zeng YM; Liu DS; Xue Q; Li JS; Hu K; Zheng YL; Gao ZC
    Chin Med J (Engl); 2021 Apr; 134(8):944-953. PubMed ID: 33813510
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial.
    Dubée V; Roy PM; Vielle B; Parot-Schinkel E; Blanchet O; Darsonval A; Lefeuvre C; Abbara C; Boucher S; Devaud E; Robineau O; Rispal P; Guimard T; d'Anglejean E; Diamantis S; Custaud MA; Pellier I; Mercat A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Clin Microbiol Infect; 2021 Aug; 27(8):1124-1130. PubMed ID: 33813110
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recovery after critical illness in COVID-19 ICU survivors.
    Parker AJ; Humbir A; Tiwary P; Mishra M; Shanmugam M; Bhatia K; Duncan A; Sharma MP; Kitchen G; Brij S; Wilde S; Martin AD; Wilson A; Brandwood C
    Br J Anaesth; 2021 Jun; 126(6):e217-e219. PubMed ID: 33812669
    [No Abstract]   [Full Text] [Related]  

  • 90. Explaining machine learning based diagnosis of COVID-19 from routine blood tests with decision trees and criteria graphs.
    Alves MA; Castro GZ; Oliveira BAS; Ferreira LA; Ramírez JA; Silva R; Guimarães FG
    Comput Biol Med; 2021 May; 132():104335. PubMed ID: 33812263
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials.
    Lin WT; Hung SH; Lai CC; Wang CY; Chen CH
    Int Immunopharmacol; 2021 Jul; 96():107602. PubMed ID: 33812260
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark.
    Kjeldsen J; Nielsen J; Ellingsen T; Knudsen T; Nielsen RG; Larsen MD; Lund K; Nørgård BM
    J Autoimmun; 2021 Jun; 120():102632. PubMed ID: 33812171
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 94. BNT 13b2 Pfizer vaccine protects against SARS-CoV-2 respiratory mucosal colonization even after prolonged exposure to positive family members.
    Edelstein S; Tannous S; Jacobs MT; Ben-Amram H; Zarka S
    J Hosp Infect; 2021 Jul; 113():192-194. PubMed ID: 33811961
    [No Abstract]   [Full Text] [Related]  

  • 95. SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy.
    Vinceti M; Filippini T; Rothman KJ; Di Federico S; Orsini N
    Environ Res; 2021 Jun; 197():111097. PubMed ID: 33811866
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2.
    Dittmar M; Lee JS; Whig K; Segrist E; Li M; Kamalia B; Castellana L; Ayyanathan K; Cardenas-Diaz FL; Morrisey EE; Truitt R; Yang W; Jurado K; Samby K; Ramage H; Schultz DC; Cherry S
    Cell Rep; 2021 Apr; 35(1):108959. PubMed ID: 33811811
    [TBL] [Abstract][Full Text] [Related]  

  • 97. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
    Mills RJ; Humphrey SJ; Fortuna PRJ; Lor M; Foster SR; Quaife-Ryan GA; Johnston RL; Dumenil T; Bishop C; Rudraraju R; Rawle DJ; Le T; Zhao W; Lee L; Mackenzie-Kludas C; Mehdiabadi NR; Halliday C; Gilham D; Fu L; Nicholls SJ; Johansson J; Sweeney M; Wong NCW; Kulikowski E; Sokolowski KA; Tse BWC; Devilée L; Voges HK; Reynolds LT; Krumeich S; Mathieson E; Abu-Bonsrah D; Karavendzas K; Griffen B; Titmarsh D; Elliott DA; McMahon J; Suhrbier A; Subbarao K; Porrello ER; Smyth MJ; Engwerda CR; MacDonald KPA; Bald T; James DE; Hudson JE
    Cell; 2021 Apr; 184(8):2167-2182.e22. PubMed ID: 33811809
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Downregulation of type III interferons in patients with severe COVID-19.
    Fukuda Y; Homma T; Inoue H; Onitsuka C; Ikeda H; Goto Y; Sato Y; Kimura T; Hirai K; Ohta S; Yamamoto M; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Med Virol; 2021 Jul; 93(7):4559-4563. PubMed ID: 33811680
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Management of anaphylaxis due to COVID-19 vaccines in the elderly.
    Bousquet J; Agache I; Blain H; Jutel M; Ventura MT; Worm M; Del Giacco S; Benetos A; Bilo BM; Czarlewski W; Abdul Latiff AH; Al-Ahmad M; Angier E; Annesi-Maesano I; Atanaskovic-Markovic M; Bachert C; Barbaud A; Bedbrook A; Bennoor KS; Berghea EC; Bindslev-Jensen C; Bonini S; Bosnic-Anticevich S; Brockow K; Brussino L; Camargos P; Canonica GW; Cardona V; Carreiro-Martins P; Carriazo A; Casale T; Caubet JC; Cecchi L; Cherubini A; Christoff G; Chu DK; Cruz AA; Dokic D; El-Gamal Y; Ebisawa M; Eberlein B; Farrell J; Fernandez-Rivas M; Fokkens WJ; Fonseca JA; Gao Y; Gavazzi G; Gawlik R; Gelincik A; Gemicioğlu B; Gotua M; Guérin O; Haahtela T; Hoffmann-Sommergruber K; Hoffmann HJ; Hofmann M; Hrubisko M; Illario M; Irani C; Ispayeva Z; Ivancevich JC; Julge K; Kaidashev I; Khaitov M; Knol E; Kraxner H; Kuna P; Kvedariene V; Lauerma A; Le LTT; Le Moing V; Levin M; Louis R; Lourenco O; Mahler V; Martin FC; Matucci A; Milenkovic B; Miot S; Montella E; Morais-Almeida M; Mortz CG; Mullol J; Namazova-Baranova L; Neffen H; Nekam K; Niedoszytko M; Odemyr M; O'Hehir RE; Okamoto Y; Ollert M; Palomares O; Papadopoulos NG; Panzner P; Passalacqua G; Patella V; Petrovic M; Pfaar O; Pham-Thi N; Plavec D; Popov TA; Recto MT; Regateiro FS; Reynes J; Roller-Winsberger RE; Rolland Y; Romano A; Rondon C; Rottem M; Rouadi PW; Salles N; Samolinski B; Santos AF; S Sarquis F; Sastre J; M G A Schols J; Scichilone N; Sediva A; Shamji MH; Sheikh A; Skypala I; Smolinska S; Sokolowska M; Sousa-Pinto B; Sova M; Stelmach R; Sturm G; Suppli Ulrik C; Todo-Bom AM; Toppila-Salmi S; Tsiligianni I; Torres M; Untersmayr E; Urrutia Pereira M; Valiulis A; Vitte J; Vultaggio A; Wallace D; Walusiak-Skorupa J; Wang DY; Waserman S; Yorgancioglu A; Yusuf OM; Zernotti M; Zidarn M; Chivato T; Akdis CA; Zuberbier T; Klimek L
    Allergy; 2021 Oct; 76(10):2952-2964. PubMed ID: 33811358
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.